Drug
Lumiracoxib clinical trials
- studies test it
- 16
- open now
- 0
- in phase 3
- 8
- first study started
- 2000
How studies write it
Studies that test it under each name
Name
Studies by the year they started
16 studies that test it; most in 2004 (5)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2003 | 3 |
| 2004 | 5 |
| 2005 | 2 |
| 2006 | 4 |
| 2012 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 1
- Phase 3
- 8
- Phase 4
- 7
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 15 · Other 1
Novartis (13) · Novartis Pharmaceuticals (2) · Hospital Central Sur de Pemex (1)
Studies
Open first, then newest update. How each study uses lumiracoxib is read from its arms, and is right about nine times in ten.
Testing it · 16
- Efficacy of Lumiracoxib in Relieving Moderate to Severe Post-dental Surgery Pain, Compared to Both Placebo and CelecoxibCompletedPhase 4Novartis PharmaceuticalsNCT00348491Written as Lumiracoxib
- Safety and Efficacy of Lumiracoxib in Patients With Osteoarthritis and With Controlled HypertensionCompletedPhase 4Novartis PharmaceuticalsNCT00267176Written as lumiracoxib
- Safety Study of Renal Function in Patients With Chronic Kidney Failure Taking Lumiracoxib or Diclofenac for ArthralgiaTerminatedPhase 2Hospital Central Sur de PemexNCT01481610Written as Lumiracoxib
- 52 Week, International, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Clinical Trial to Compare Retention on Treatment, Safety, Tolerability & Efficacy of Lumiracoxib 100 mg od, Lumiracoxib 100 mg Bid & Celecoxib 200 mg od in Pts With Primary OA of Hip, Knee, Hand or SpineCompletedPhase 3NovartisNCT00145301Written as Lumiracoxib
- 6 Week Open-label Trial With Lumiracoxib 200mg o.d. in Primary Knee Osteoarthritis or Rheumatoid ArthritisCompletedPhase 3NovartisNCT00170872Written as Lumiracoxib
- Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA)CompletedPhase 3NovartisNCT00476034Written as lumiracoxib
- Efficacy and Safety Study of Lumiracoxib in Patients With Primary Hip OsteoarthritisCompletedPhase 3NovartisNCT00154219Written as Lumiracoxib (drug)
- Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis(OA)CompletedPhase 3NovartisNCT00475800Written as Lumiracoxib
- Efficacy and Safety of Lumiracoxib in Patients With Knee Osteoarthritis (OA).CompletedPhase 3NovartisNCT00366938Written as Lumiracoxib
- Efficacy and Safety of LumiracoxibCompletedPhase 3NovartisNCT00267215Written as Lumiracoxib
- Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA)CompletedPhase 3NovartisNCT00367315Written as Lumiracoxib
- Efficacy and Safety of Lumiracoxib 400 mg in Arthroscopic Knee SurgeryCompletedPhase 4NovartisNCT00333567Written as Lumiracoxib
- Video Capsule Endoscopy to Investigate the Safety and Tolerability of Lumiracoxib in the Small BowelCompletedPhase 4NovartisNCT00350155Written as Lumiracoxib
- Effects of Lumiracoxib and Ibuprofen on Blood Pressure and Urinary Eicosanoid Excretion in Osteoarthritis Patients With Controlled HypertensionCompletedPhase 4NovartisNCT00419796Written as Lumiracoxib
- Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of GoutCompletedPhase 4NovartisNCT00170781Written as Lumiracoxib
- Safety and Efficacy of Lumiracoxib Versus Naproxen in Acute Musculoskeletal PainCompletedPhase 4NovartisNCT00170898Written as Lumiracoxib
Codes
What other systems call lumiracoxib · ClinicalTrials.gg INT004524
- MeSH (NLM) C473384lumiracoxibConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) V91T9204HULUMIRACOXIBConfirmed FDA, NLM, Wikidata
- Wikidata Q413744lumiracoxibConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C66041LumiracoxibOne source FDA
- DrugBank DB01283One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C473384 | lumiracoxib | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | V91T9204HU | LUMIRACOXIB | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q413744 | lumiracoxib | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C66041 | Lumiracoxib | One source FDA |
| DrugBank | DB01283 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.